ConductScience.org, home

Paper4175641

Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases.

Yokoi S and 3 others. Arch Neurol, 1968. Cited by 121 papers, by iCite.

Cite this record

ConductScience Library. Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases. Papers, record 4175641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4175641

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases.
PubMed
Journal
Arch Neurol
PubMed
Year
1968
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
121
iCite
Revised in PubMed
2019-07-17
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yokoi SS
2Austin JJ
3Witmer FF
4Sakai MM

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cerebral CortexMajor topic
Cytoplasmic GranulesMajor topic
EpilepsyMajor topic
MyoclonusMajor topic
Adolescent
Adult
Amylases
Carbohydrates
Chemical Phenomena
Chemistry
Chromatography, Thin Layer
Glucose
Glycogen Storage Disease
Histocytochemistry
Humans
Iodine
Microscopy, Electron
Nerve Degeneration
Nerve Tissue Proteins
Polymers
Spectrophotometry
Spectrum Analysis
Staining and Labeling

Source PubMed

Download CSV of topics

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 121 citations.

PMIDTitleJournalYearIn PapersSource
41465357Adeno-Associated Virus-Based Gene Therapy for Lafora Disease in Epm2b-Deficient Mice.Int J Mol Sci2025https://conductscience.org/library/papers/41465357PubMed
41169091Advances in gene therapy for Lafora disease: Intravenous recombinant adeno-associated virus-mediated delivery of EPM2A and EPM2B genes.Clin Transl Med2025https://conductscience.org/library/papers/41169091PubMed
39301689Neuromuscular junction dysfunction in Lafora disease.Dis Model Mech2024https://conductscience.org/library/papers/39301689PubMed
38796707Gene therapy for Lafora disease in the Epm2a-/- mouse model.Mol Ther2024https://conductscience.org/library/papers/38796707PubMed
38341935Effect of intracerebroventricular administration of alglucosidase alfa in two mouse models of Lafora disease: Relevance for clinical practice.Epilepsy Res2024https://conductscience.org/library/papers/38341935PubMed
35804532Lafora Disease and Alpha-Synucleinopathy in Two Adult Free-Ranging Moose (Alces alces) Presenting with Signs of Blindness and Circling.Animals (Basel)2022https://conductscience.org/library/papers/35804532PubMed
34069559Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease.Int J Mol Sci2021https://conductscience.org/library/papers/34069559PubMed
32660096Starch and Glycogen Analyses: Methods and Techniques.Biomolecules2020https://conductscience.org/library/papers/32660096PubMed
32475552Polyglucosan body structure in Lafora disease.Carbohydr Polym2020https://conductscience.org/library/papers/32475552PubMed
31667805Brain Glycogen Structure and Its Associated Proteins: Past, Present and Future.Adv Neurobiol2019https://conductscience.org/library/papers/31667805PubMed
31353261Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion.Cell Metab2019https://conductscience.org/library/papers/31353261PubMed
31329461Central Nervous System Delivery and Biodistribution Analysis of an Antibody-Enzyme Fusion for the Treatment of Lafora Disease.Mol Pharm2019https://conductscience.org/library/papers/31329461PubMed
29483193Lafora disease offers a unique window into neuronal glycogen metabolism.J Biol Chem2018https://conductscience.org/library/papers/29483193PubMed
28800070Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan.Int J Mol Sci2017https://conductscience.org/library/papers/28800070PubMed
26231210Mechanistic Insights into Glucan Phosphatase Activity against Polyglucan Substrates.J Biol Chem2015https://conductscience.org/library/papers/26231210PubMed
25699013Changing shapes of glycogen-autophagy nexus in neurons: perspective from a rare epilepsy.Front Neurol2015https://conductscience.org/library/papers/25699013PubMed
25544560Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease.Mol Cell2015https://conductscience.org/library/papers/25544560PubMed
25309313Enhanced sensitivity of laforin- and malin-deficient mice to the convulsant agent pentylenetetrazole.Front Neurosci2014https://conductscience.org/library/papers/25309313PubMed
24914213Protein degradation and quality control in cells from laforin and malin knockout mice.J Biol Chem2014https://conductscience.org/library/papers/24914213PubMed
24472629Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease.Mol Brain2014https://conductscience.org/library/papers/24472629PubMed

See all 66 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4175641

GET https://conductscience.org/api/papers/v1/4175641/cited_by?page=2